Skip to content
    Compare notes on r/BodyHackGuideCompare notes with other researchers. Join r/BodyHackGuide

    Melanotan I vs Snap-8

    Side-by-side comparison of Melanotan I and Snap-8: mechanism, half-life, dose range, safety profile, and vendor pricing.

    Melanotan I from $35.00
    Snap-8 from $34.99

    Price snapshot

    Melanotan I

    Current low
    $35.00
    current listings
    7-day low
    —
    not enough history yet
    30-day low
    —
    not enough history yet
    30-day change
    —
    not enough history yet

    Snap-8

    Current low
    $34.99
    current listings
    7-day low
    —
    not enough history yet
    30-day low
    —
    not enough history yet
    30-day change
    —
    not enough history yet

    Melanotan I

    Melanotan I (afamelanotide) is a linear synthetic analog of alpha-melanocyte-stimulating hormone (α-MSH) with the substitution of norleucine at position 4 and D-phenylalanine at position 7. Unlike Melanotan II (which is…

    Lowest listed price: $35.00 across 4 listings

    Full Melanotan I profile

    Snap-8

    Snap-8 (INCI: Acetyl Glutamyl Heptapeptide-1) is a synthetic octapeptide designed as an analog of the N-terminal fragment of synaptosomal-associated protein of 25 kDa (SNAP-25), which is the molecular target of botulinum…

    Lowest listed price: $34.99 across 4 listings

    Full Snap-8 profile

    Side-by-side comparison

    Attribute Melanotan I Snap-8
    Category Other Skin & Hair
    Research Stage FDA Approved Preclinical
    Mechanism of Action Melanotan I is afamelanotide, i.e. [Nle4, D-Phe7]-alpha-MSH ('NDP-alpha-MSH'), a synthetic 13-amino-acid analog of alpha-melanocyte-stimulating hormone. The Nle4 and D-Phe7 substitutions make it resistant to enzymatic breakdown and roughly 10-100x more potent… Snap-8 (INCI Acetyl Octapeptide-3; CAS 868844-74-0) is a synthetic octapeptide, Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH2, whose sequence mimics the N-terminal domain of SNAP-25. SNAP-25, together with Syntaxin-1 and VAMP/synaptobrevin, forms the SNARE complex…
    Half-Life Controlled-release subcutaneous implant (Scenesse): high inter-subject variability; median Tmax ~36 h, mean Cmax ~3.7 ng/mL, apparent terminal half-life ~15 h, with plasma levels measurable to ~96 h post-dose (FDA pharmacokinetics, n=12). Injected/bolus free peptide: peak plasma at ~1-2 h with an elimination half-life of ~30 minutes; the Nle4/D-Phe7 modifications prolong biological (melanogenic) activity well beyond plasma clearance. Not characterized (topical peptide)
    Typical Dose Range 16 mg —
    Dosing Frequency every_1_to_4_weeks twice_daily
    Administration Subcutaneous, Intramuscular Topical
    Side Effects Generally mild. Commonly reported: transient nausea (usually milder and less frequent than with Melanotan II), facial flushing, headache, fatigue, and skin hyperpigmentation including darkening of existing moles, freckles and nevi. Implant-site reactions occur… Topical use at cosmetic concentrations is generally well tolerated. The most commonly reported effects are mild, transient local reactions such as erythema, tightness, dryness, or stinging, usually at higher concentrations or on sensitive/periocular skin.…
    Molecular Weight 1646.85 g/mol (average; molecular formula C78H111N21O19) 1075.16 g/mol
    Common Vial Sizes 5, 10 10

    Price History

    2 data points
    • Ion Peptide
    • Disguised Alpha

    Price History

    3 data points
    • Ion Peptide
    • OF
    • Disguised Alpha

    Melanotan I: potential benefits

    • Increased melanin (eumelanin) production and skin darkening via MC1R activation, with a reduced UV requirement
    • FDA-approved photoprotection in erythropoietic protoporphyria (EPP) as the Scenesse 16 mg subcutaneous implant [PMID:26132941]
    • Reduced phototoxic pain and improved quality of life in EPP patients in randomized controlled trials [PMID:26132941]
    • Tends to produce fewer MC4R-type effects (spontaneous erections, strong libido, marked nausea) than the cyclic Melanotan II - attributable to Melanotan II's greater potency and metabolic stability, not to true MC1R selectivity of Melanotan I
    • Investigated in research settings for photoprotection in UV-sensitive populations

    Snap-8: potential benefits

    • Reduction of dynamic expression wrinkles (forehead, crow's feet, glabellar lines)
    • SNARE complex interference — partial, reversible neuromuscular inhibition
    • Topical alternative research model for neuromuscular relaxation without injected toxin
    • Cosmetic peptide compounding research — high-purity raw powder applications
    • Synergy with Argireline (Acetyl Hexapeptide-3) in SNARE-targeting formulations

    Frequently asked

    What's the difference between Melanotan I and Snap-8?

    Melanotan I is a other that melanotan i is afamelanotide, i.e. [nle4, d-phe7]-alpha-msh ('ndp-alpha-msh'), a synthetic 13-amino-acid analog of alpha-melanocyte-stimulating hormone. the nle4 and d-phe7…. Snap-8 is a skin & hair that snap-8 (inci acetyl octapeptide-3; cas 868844-74-0) is a synthetic octapeptide, ac-glu-glu-met-gln-arg-arg-ala-asp-nh2, whose sequence mimics the n-terminal domain of snap-25.…. The two differ in mechanism, half-life (Controlled-release subcutaneous implant (Scenesse): high inter-subject variability; median Tmax ~36 h, mean Cmax ~3.7 ng/mL, apparent terminal half-life ~15 h, with plasma levels measurable to ~96 h post-dose (FDA pharmacokinetics, n=12). Injected/bolus free peptide: peak plasma at ~1-2 h with an elimination half-life of ~30 minutes; the Nle4/D-Phe7 modifications prolong biological (melanogenic) activity well beyond plasma clearance. vs Not characterized (topical peptide)), and typical dose range.

    Which has the longer half-life, Melanotan I or Snap-8?

    Melanotan I has a half-life of Controlled-release subcutaneous implant (Scenesse): high inter-subject variability; median Tmax ~36 h, mean Cmax ~3.7 ng/mL, apparent terminal half-life ~15 h, with plasma levels measurable to ~96 h post-dose (FDA pharmacokinetics, n=12). Injected/bolus free peptide: peak plasma at ~1-2 h with an elimination half-life of ~30 minutes; the Nle4/D-Phe7 modifications prolong biological (melanogenic) activity well beyond plasma clearance.. Snap-8 has a half-life of Not characterized (topical peptide). Longer half-lives generally mean less frequent dosing but slower on/off kinetics.

    Which is cheaper, Melanotan I or Snap-8?

    Lowest listed price on BodyHackGuide: Melanotan I from $35.00, Snap-8 from $34.99. Prices are pulled from the vendor listings tracked on BHG and change frequently. See the compare tables on each compound page for the current set of offers.

    Can you stack Melanotan I and Snap-8?

    Stacking depends on mechanism overlap, safety profile, and goals. Melanotan I and Snap-8 should only be stacked after reviewing each compound's individual protocol page, side effect profile, and any published interaction data. Use the BodyHackGuide stack builder for a structured review before combining research compounds.

    See current vendor prices

    Listings from the vendors we track. Prices change often, so check the vendor before you buy.

    Melanotan I prices Snap-8 prices Compare all compounds

    Before you buy Melanotan I or Snap-8

    Check the vendor trust score. Every supplier we track is rated 0-100 on COA verification, payment transparency, shipping, reviews, and listings: one published, reproducible methodology, applied to every vendor.

    View Vendor Scorecard

    Related comparisons

    Melanotan I vs Melanotan Ii

    Research use only. BodyHackGuide is a research and price-comparison reference. The compounds discussed on this page are not approved by the FDA for human consumption and are sold strictly for laboratory research. Prices shown are pulled from vendor listings tracked on BHG and are subject to change. Every vendor is ranked on the same public, reproducible methodology. See editorial standards and affiliate disclosure.